A clinical study of chimeric antigen receptor T-cell immunotherapy in the treatment of CD19+ B-cell hematologic malignancies

Category Primary study
Registry of TrialsChinese Clinical Trial Register
Year 2016
This article has no abstract
Epistemonikos ID: 544860aad097b0082756fae5aa84c57046d019db
First added on: Apr 16, 2025